stoxline Quote Chart Rank Option Currency Glossary
  
Heart Test Laboratories, Inc. (HSCS)
3.91  0.105 (2.76%)    02-14 16:00
Open: 3.8
High: 4.08
Volume: 19,625
  
Pre. Close: 3.805
Low: 3.79
Market Cap: 4(M)
Technical analysis
2025-02-14 4:48:44 PM
Short term     
Mid term     
Targets 6-month :  4.76 1-year :  5.56
Resists First :  4.07 Second :  4.76
Pivot price 3.56
Supports First :  3.47 Second :  3.09
MAs MA(5) :  3.79 MA(20) :  3.52
MA(100) :  3.51 MA(250) :  5.63
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  81.6 D(3) :  79.6
RSI RSI(14): 62.3
52-week High :  18.5 Low :  2.35
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ HSCS ] has closed below upper band by 16.2%. Bollinger Bands are 22.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 4.09 - 4.11 4.11 - 4.13
Low: 3.73 - 3.76 3.76 - 3.79
Close: 3.87 - 3.91 3.91 - 3.95
Company Description

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Headline News

Mon, 16 Dec 2024
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results - GlobeNewswire

Wed, 13 Nov 2024
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - GlobeNewswire

Tue, 24 Sep 2024
Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket - Benzinga

Tue, 24 Sep 2024
"Nasdaq Stocks Set for Explosive Growth: BNZI, SEEL, PRSO, MSS, HSCS Revamp for Big Potential" - openPR

Tue, 24 Sep 2024
“Nasdaq Stocks Set for Explosive Growth: BNZI, SEEL, PRSO, MSS, HSCS Revamp for Big Potential” - Barchart

Thu, 12 Sep 2024
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 0 (M)
Shares Float 1 (M)
Held by Insiders 826300 (%)
Held by Institutions 10.6 (%)
Shares Short 23 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -7.02e+006
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -37 %
Return on Assets (ttm) 907.4 %
Return on Equity (ttm) -81.7 %
Qtrly Rev. Growth 18600 %
Gross Profit (p.s.) 0
Sales Per Share -81.86
EBITDA (p.s.) 3805.47
Qtrly Earnings Growth 5.3 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -7 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.05
Price to Cash Flow 1.18
Stock Dividends
Dividend 0
Forward Dividend 54950
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android